Balance Sheet

Assets

+22%

+46%

10Y

Currency: USD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	114	97	47	67	62	60	79	107	157	184	224	279	323	129	155	188	124	90	384	144	113	454	288	180
Cash Equivalents	114	97	47	67	62	60	79	107	157	184	224	279	323	129	155	188	124	90	384	144	113	454	288	180
Short-Term Investments	33	124	90	66	35	0	0	0	0	0	0	0	0	214	237	284	0	0	0	0	0	0	0	0
Total Receivables	46	54	66	72	81	108	111	115	120	141	138	158	181	200	232	270	273	307	375	426	491	530	561	693
Accounts Receivables	46	54	66	72	81	108	111	115	120	141	138	158	152	188	204	235	259	287	355	406	442	513	534	628
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	29	12	28	35	14	21	19	19	48	17	27	65
Inventory	75	75	76	69	96	99	116	110	128	133	141	133	160	189	158	164	173	195	210	269	368	380	382	378
Other Current Assets	20	21	22	25	28	38	50	44	56	66	66	82	95	90	64	66	84	87	94	117	130	132	168	163
Total Current Assets	288	371	302	299	302	306	356	376	461	524	570	653	759	822	846	972	654	680	1 063	956	1 101	1 495	1 400	1 414
PP&E Net	49	45	63	66	100	142	190	200	202	217	245	281	304	333	357	379	437	614	646	693	768	818	829	871
PP&E Gross	49	45	63	66	100	142	190	200	202	217	245	281	304	333	357	379	437	614	646	693	768	818	829	871
Accumulated Depreciation	66	67	75	77	92	113	131	147	175	206	233	269	300	346	385	433	469	519	587	648	706	785	835	926
Intangible Assets	4	7	32	31	43	78	68	64	56	69	63	59	65	56	46	44	42	58	53	99	98	85	112	110
Goodwill	52	55	93	88	105	158	139	149	149	173	175	181	184	179	178	200	214	240	243	359	362	366	405	414
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31	81	98	124	150	168	186	237
Long-Term Investments	16	35	20	0	0	0	0	0	0	0	0	0	11	12	11	10	11	14	12	19	56	56	58	58
Other Long-Term Assets	8	9	6	7	9	18	13	20	30	48	51	57	61	73	92	109	147	145	180	188	213	272	304	247
Other Assets	52	55	93	88	105	158	139	149	149	173	175	181	184	179	178	200	214	240	243	359	362	366	405	414
Total Assets	417 N/A	522 +25%	514 -1%	491 -5%	560 +14%	702 +25%	765 +9%	809 +6%	897 +11%	1 031 +15%	1 104 +7%	1 231 +11%	1 384 +12%	1 475 +7%	1 531 +4%	1 713 +12%	1 537 -10%	1 832 +19%	2 295 +25%	2 437 +6%	2 747 +13%	3 260 +19%	3 293 +1%	3 351 +2%
Liabilities
Accounts Payable	9	19	15	20	24	33	28	19	23	37	35	30	45	53	60	67	70	72	75	116	110	111	114	110
Accrued Liabilities	43	49	56	56	70	89	91	95	106	124	133	127	164	185	211	224	233	289	373	416	385	392	440	441
Short-Term Debt	1	0	1	1	0	72	151	119	129	243	212	277	549	573	611	655	399	289	0	74	579	250	250	398
Current Portion of Long-Term Debt	0	0	0	0	1	1	1	1	1	1	1	1	0	0	0	0	0	0	50	75	75	75	168	75
Other Current Liabilities	16	32	28	30	29	29	25	23	26	33	25	43	63	46	52	59	69	75	85	83	86	124	96	124
Total Current Liabilities	70	100	100	107	125	223	295	256	285	437	406	478	821	857	935	1 005	770	725	583	764	1 236	952	1 068	1 149
Long-Term Debt	0	0	1	0	6	6	5	4	3	3	1	150	350	500	499	500	500	599	858	775	694	623	450	375
Deferred Income Tax	0	0	8	6	7	15	12	18	19	23	23	34	42	49	39	25	29	33	12	9	8	7	11	32
Minority Interest	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0
Other Liabilities	6	7	7	9	11	20	15	15	16	29	37	50	54	153	166	238	247	297	209	199	200	194	169	190
Total Liabilities	76 N/A	109 +42%	117 +7%	122 +4%	150 +23%	264 +76%	327 +24%	294 -10%	323 +10%	491 +52%	467 -5%	712 +52%	1 267 +78%	1 559 +23%	1 639 +5%	1 768 +8%	1 547 -12%	1 655 +7%	1 662 +0%	1 747 +5%	2 138 +22%	1 775 -17%	1 698 -4%	1 745 +3%
Equity
Common Stock	4	5	5	6	7	12	12	14	14	15	15	15	15	16	16	16	15	15	15	16	16	16	17	17
Retained Earnings	183	240	319	397	491	586	702	824	966	1 127	1 306	1 493	1 675	318	540	804	1 168	1 596	2 176	2 920	3 600	4 445	5 332	6 392
Additional Paid In Capital	334	383	411	437	480	515	549	581	642	703	757	825	888	941	1 012	1 074	1 138	1 214	1 295	1 377	1 463	1 570	1 674	1 827
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock	178	219	348	472	578	697	830	915	1 061	1 320	1 457	1 829	2 453	1 316	1 633	1 912	2 289	2 601	2 800	3 571	4 392	4 475	5 334	6 561
Other Equity	3	5	11	1	11	23	6	10	13	15	16	14	8	42	43	36	42	46	53	53	78	71	94	69
Total Equity	341 N/A	413 +21%	398 -4%	369 -7%	410 +11%	438 +7%	438 0%	515 +17%	574 +12%	540 -6%	636 +18%	518 -19%	118 -77%	84 N/A	108 -29%	54 +50%	10 +82%	177 N/A	632 +256%	690 +9%	609 -12%	1 485 +144%	1 595 +7%	1 605 +1%
Total Liabilities & Equity	417 N/A	522 +25%	514 -1%	491 -5%	560 +14%	702 +25%	765 +9%	809 +6%	897 +11%	1 031 +15%	1 104 +7%	1 231 +11%	1 384 +12%	1 475 +7%	1 531 +4%	1 713 +12%	1 537 -10%	1 832 +19%	2 295 +25%	2 437 +6%	2 747 +13%	3 260 +19%	3 293 +1%	3 351 +2%
Shares Outstanding
Common Shares Outstanding	135	139	132	127	125	122	118	116	115	110	109	103	95	90	88	87	86	85	85	85	83	83	82	80

Income Statement Balance Sheet Cash Flow Statement

IDEXX Laboratories Inc
NASDAQ:IDXX

Balance Sheet

Balance Sheet Decomposition
IDEXX Laboratories Inc

Balance Sheet
IDEXX Laboratories Inc

See Also

Company

Help

Tools

Stocks

IDEXX Laboratories Inc NASDAQ:IDXX

Balance Sheet

Balance Sheet Decomposition IDEXX Laboratories Inc

Balance Sheet IDEXX Laboratories Inc

See Also

Company

Help

Tools

Stocks

IDEXX Laboratories Inc
NASDAQ:IDXX

Balance Sheet Decomposition
IDEXX Laboratories Inc

Balance Sheet
IDEXX Laboratories Inc